Catalyst Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-65
Closed -$75K 417
2016
Q1
$75K Hold
65
0.01% 308
2015
Q4
$142K Hold
65
0.02% 293
2015
Q3
$76K Buy
65
+45
+225% +$7.09K 0.01% 346
2015
Q2
$47K Buy
+20
New +$3.2K 0.01% 363

Other funds holding AMGN

Catalyst Capital Advisors's AMGN Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $18.8K and leaving 149 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Catalyst Capital Advisors first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.1M in Q4 2018. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Catalyst Capital Advisors held 149 shares of Amgen worth $54K as of Q2 2026.
  • Catalyst Capital Advisors sold 55 Amgen shares in Q2 2026, an estimated $18.8K.
  • Amgen made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #288 holding.
  • Catalyst Capital Advisors first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
  • Catalyst Capital Advisors's Amgen position peaked at $22.1M in Q4 2018.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.